Taken together, the results indicate that EHD1 is a critical factor controlling β2AR expression, that β2AR has no impact on EHD1, and that EHD1 activates β2AR signaling in NSCLC. This evidence concerns the gene ADRB2 and non-small cell lung carcinoma.